FSHβ & FOXP3 Antibodies: Core Tools for Reproductive Endocrinology and Treg Cell Immunology Research

Concept

Reproductive biology and immunology—two cornerstones of human health—rely on target-specific, high-performance antibodies to dissect the molecular mechanisms governing hormone regulation and immune homeostasis. Follicle-Stimulating Hormone β (FSHβ), the biologically active subunit of FSH, is the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, controlling gametogenesis, sex hormone synthesis and reproductive development. FOXP3, the definitive transcription factor of regulatory T cells (Treg), orchestrates immune tolerance, preventing autoimmunity and modulating tumor immunosuppression. Unraveling the complex pathways of reproductive endocrinology and Treg cell biology demands ultra-specific antibodies that enable precise detection, localization and functional analysis of these key molecules. As a global leader in life science reagents, ANT BIO PTE. LTD. delivers industry-leading solutions for both research fields via its Starter sub-brand (flagship antibodies)—offering recombinant rabbit monoclonal FSHβ antibodies optimized for reproductive endocrinology and a portfolio of fluorescently labeled/unconjugated FOXP3 antibodies for Treg cell research. All Starter antibodies are rigorously validated for specificity, sensitivity and batch consistency, serving as gold-standard tools for basic research, clinical translation and diagnostic development in reproductive medicine and immunology worldwide.

Research Frontiers

FSHβ/reproductive endocrinology and FOXP3/Treg cell immunology research are at the cutting edge of modern biomedical science, driving breakthroughs in infertility treatment, reproductive disorder diagnosis, immunotherapy development and immune disease research. ANT BIO PTE. LTD.’s FSHβ and FOXP3 antibodies enable transformative discoveries in key high-impact research and clinical frontiers that are redefining our approach to reproductive health and immune homeostasis:

FSHβ in Reproductive Endocrinology & Reproductive Medicine

1. FSHβ glycosylation and structure-function relationships: Dissecting how site-specific glycosylation of FSHβ modulates its bioactivity, receptor-binding capacity and circulatory half-life—uncovering novel targets for engineering long-acting FSH analogs for infertility treatment.
2. HPG axis regulation in health and disease: Investigating the molecular mechanisms governing FSHβ synthesis and secretion in pituitary gonadotrophs, and how dysregulation contributes to reproductive disorders such as polycystic ovary syndrome (PCOS), premature ovarian failure (POF) and hypopituitarism.
3. FSHβ as a diagnostic biomarker: Validating FSHβ levels as a precise indicator of ovarian reserve, pituitary function and testicular health—improving the diagnosis and prognosis of infertility and reproductive endocrine disorders.
4. Targeted therapy for reproductive disorders: Developing FSHβ neutralizing antibodies and small-molecule modulators to treat conditions such as ovarian hyperstimulation syndrome (OHSS) and gonadotroph adenomas, and engineering novel ovulation-inducing agents with improved efficacy and safety.
5. FSH in aging and reproductive senescence: Studying age-related changes in FSHβ expression and FSH signaling—uncovering the molecular basis of ovarian and testicular senescence and developing interventions to preserve reproductive function.

FOXP3 & Treg Cell Immunology

1. Treg cell plasticity and functional stability: Dissecting the molecular mechanisms by which FOXP3 maintains Treg cell identity and function, and how environmental cues (e.g., inflammation, tumor microenvironment) induce FOXP3 downregulation and Treg cell plasticity—key to developing Treg cell-based immunotherapies.
2. FOXP3-mediated tumor immunosuppression: Investigating the role of FOXP3+ Treg cells in shaping the tumor immune microenvironment (TME), and developing strategies to deplete or inhibit Treg cell function in the TME to enhance anti-tumor immune responses and reverse immune checkpoint inhibitor resistance.
3. FOXP3 in autoimmune disease pathogenesis: Studying quantitative and functional defects of FOXP3+ Treg cells in autoimmune diseases (e.g., systemic lupus erythematosus (SLE), rheumatoid arthritis (RA))—identifying novel targets for restoring immune tolerance and treating immune dysregulation disorders.
4. FOXP3 as a predictive immunotherapy biomarker: Validating FOXP3 expression levels and Treg cell infiltration as predictive markers for the efficacy of immune checkpoint inhibitors (ICIs) in cancer and for transplant rejection risk in organ transplantation.
5. FOXP3 structural biology and modulator development: Exploring the structure-function relationship of FOXP3 (head-to-head vs. domain-swapped dimers) and identifying small-molecule compounds that target FOXP3 to regulate Treg cell function for therapeutic purposes.

Research Significance

FSHβ and FOXP3 antibodies are indispensable tools in reproductive endocrinology and immunology research, with their use driving paradigm shifts in our understanding of reproductive health, immune homeostasis and disease pathogenesis. ANT BIO PTE. LTD.’s high-performance FSHβ and FOXP3 antibodies amplify the scientific and clinical significance of this research, with far-reaching implications for patient care, drug development and biomedical innovation:

FSHβ Antibodies: The Gold Standard for Reproductive Endocrinology Research

1. Definitive tool for FSH-specific detection: FSHβ is the subunit that confers biological specificity to the FSH heterodimer (shared α subunit with LH/TSH), and FSHβ antibodies enable highly specific detection of FSH without cross-reactivity with other glycoprotein hormones—an essential feature for accurate hormone quantification and localization.
2. Key to understanding HPG axis function: FSHβ antibodies enable precise quantification of FSH levels in serum, tissue and cell culture supernatants, and in situ localization of FSHβ in pituitary gonadotrophs—uncovering the molecular mechanisms governing FSH synthesis, secretion and signaling in the HPG axis.
3. Critical for reproductive disorder diagnosis: FSHβ antibodies form the core of immunoassays for measuring serum FSH levels, a key clinical biomarker for assessing ovarian reserve, pituitary function and testicular health—guiding the diagnosis and treatment of infertility, PCOS, POF and other reproductive endocrine disorders.
4. Essential for reproductive drug development: FSHβ antibodies are used to construct drug screening platforms for identifying small-molecule modulators of FSH signaling, and as quality control tools for recombinant FSH biosimilars—driving the development of novel ovulation-inducing agents, contraceptives and targeted therapies for reproductive disorders.
5. Bridging basic research and clinical translation: FSHβ antibodies enable the validation of novel molecular targets discovered in basic reproductive endocrinology research on clinical samples—accelerating the translation of scientific discoveries into clinical diagnostic tools and reproductive medicine treatments.

FOXP3 Antibodies: The Definitive Marker for Treg Cell Research

1. Unique tool for Treg cell identification: FOXP3 is the master transcription factor and specific marker of Treg cells, and FOXP3 antibodies are the only tool for accurately identifying, sorting and quantifying FOXP3+ Treg cells from peripheral blood, tissues and in vitro cultures—an essential first step for all Treg cell research.
2. Key to understanding immune homeostasis: FOXP3 antibodies enable the study of Treg cell distribution, quantity and functional status in normal and pathological conditions—uncovering the role of Treg cells in maintaining immune tolerance, preventing autoimmunity and regulating inflammatory responses.
3. Critical for tumor immunology and immunotherapy: FOXP3 antibodies allow the evaluation of Treg cell infiltration in the TME, a major driver of tumor immunosuppression and poor prognosis—providing critical insights for developing Treg cell-targeted immunotherapies and predicting the efficacy of ICIs.
4. Essential for immune disease research: FOXP3 antibodies are used to study Treg cell defects in autoimmune diseases (SLE, RA) and primary immunodeficiency diseases (e.g., IPEX syndrome, caused by FOXP3 gene mutations)—uncovering the immune mechanisms underlying these diseases and identifying novel therapeutic targets.
5. Core tool for immunotherapy development: FOXP3 antibodies serve as quality control tools for Treg cell-based adoptive cell therapy products, and as biomarkers for assessing the impact of immunotherapies (e.g., CAR-T, ICIs) on Treg cell function—driving the development of novel immunotherapies for cancer, autoimmune diseases and transplant rejection.

Together, FSHβ and FOXP3 antibodies form a powerful toolset for advancing two critical areas of biomedical research—reproductive endocrinology and immunology—enabling the translation of basic scientific discoveries into clinical treatments that improve human health and quality of life.

Related Mechanisms, Research Methods & Product Applications

1. FSHβ: Master Regulator of the HPG Axis – Mechanisms and Antibody Applications

Follicle-Stimulating Hormone β (FSHβ) is a 111-amino acid glycoprotein subunit that forms the biologically active FSH heterodimer with a common α subunit (shared with LH, TSH and hCG). Synthesized and secreted by pituitary gonadotrophs, FSHβ confers the unique biological specificity of FSH, and its site-specific glycosylation (Asn7, Asn24) modulates FSH bioactivity, receptor (FSHR) binding capacity, circulatory half-life and metabolic clearance. FSH binds to FSHR on ovarian granulosa cells and testicular Sertoli cells, activating the cAMP/PKA signaling pathway to regulate gametogenesis (oocyte maturation and spermatogenesis), sex hormone synthesis (estradiol, inhibin) and the development and maintenance of the reproductive system. Dysregulation of FSHβ synthesis, secretion or signaling leads to a wide range of reproductive endocrine disorders, including infertility, PCOS, POF and hypogonadism.

Core Applications of FSHβ Antibodies in Reproductive Endocrinology Research

ANT BIO PTE. LTD.’s Starter S-RMab® FSHβ recombinant rabbit monoclonal antibody (S0B2271) is optimized for IHC, IF, WB and ELISA, enabling comprehensive FSHβ detection and analysis across all key experimental platforms. Key applications include:

1. Hormone quantification and secretion analysis (ELISA/WB): Highly specific and sensitive detection of FSHβ/FSH levels in serum, pituitary tissue lysates and cell culture supernatants—quantifying FSH secretion and studying its dynamic changes under physiological (estrous cycle, puberty, aging) and pathological (PCOS, POF) conditions.
2. In situ localization and expression analysis (IHC/IF): Precise localization of FSHβ in pituitary gonadotrophs (adenohypophysis) and semi-quantitative analysis of FSHβ expression—studying pituitary function, gonadotroph differentiation and the pathogenesis of pituitary adenomas (e.g., gonadotroph adenomas).
3. Protein interaction and signaling studies (Co-IP/WB): Capture of FSHβ/FSH-interacting protein complexes and analysis of downstream signaling molecules (cAMP, PKA)—unraveling the molecular networks regulating FSH synthesis, secretion and signal transduction.
4. Clinical diagnostic development (ELISA/IHC): Core detection reagent for developing immunoassays to measure serum FSH levels—assessing ovarian reserve, pituitary function and testicular health for infertility diagnosis and reproductive disorder screening.
5. Drug development and quality control (ELISA/WB): Screening of small-molecule modulators of FSH signaling (ovulation inducers, contraceptives) and quality control of recombinant FSH biosimilars (purity, activity, consistency)—driving the development of novel reproductive medicine drugs.

2. FOXP3: Master Transcription Factor of Treg Cells – Mechanisms and Antibody Applications

FOXP3 (Forkhead Box P3) is a nuclear transcription factor and the definitive marker of regulatory T cells (Treg), a subset of CD4+ T cells that play a pivotal role in maintaining immune homeostasis and tolerance. FOXP3 expression in Treg cells is tightly regulated by multiple signaling pathways (TCR/NFAT, IL-2/STAT5, CD28/Akt/mTOR), and stable FOXP3 expression is essential for Treg cell development, differentiation and functional maintenance. The FOXP3 protein forms a transcriptionally active head-to-head dimer (via a Runx1-binding region) that regulates the expression of downstream target genes, while a domain-swapped dimer abrogates its activity, leading to loss of Treg cell function and immune dysregulation. FOXP3+ Treg cells suppress excessive immune responses to prevent autoimmunity, but their accumulation in the TME drives tumor immunosuppression, and their functional defects cause autoimmune diseases and primary immunodeficiencies (e.g., IPEX syndrome).

Core Applications of FOXP3 Antibodies in Immunology Research

ANT BIO PTE. LTD.’s Starter FOXP3 antibody portfolio (fluorescently labeled: Alexa Fluor® 488/647, FITC; unconjugated) is optimized for flow cytometry, IF, IHC and WB, enabling precise Treg cell identification, localization and functional analysis. Key applications include:

1. Treg cell identification and sorting (Flow Cytometry): Fluorescently labeled FOXP3 antibodies paired with CD4/CD25 surface markers enable accurate quantification and sorting of FOXP3+CD4+CD25+ Treg cells from peripheral blood, lymphoid tissues and tumor-infiltrating lymphocytes (TILs)—the gold standard for Treg cell isolation and functional study.
2. In situ tissue localization (IHC/IF): Detection of FOXP3+ Treg cell infiltration in tumor tissues, inflammatory lesions and transplant grafts—providing spatial information about Treg cell distribution and its correlation with disease progression, immune suppression and treatment response.
3. Protein expression and functional analysis (WB/IF): Quantitative analysis of FOXP3 protein expression levels in cell lysates and tissue homogenates—studying dynamic changes in FOXP3 expression under inflammatory, tumorigenic and immunotherapeutic conditions.
4. Clinical disease research and biomarker detection (Flow Cytometry/IHC): Evaluation of Treg cell quantity and function in autoimmune diseases (SLE, RA), cancer and transplant patients—serving as a biomarker for disease prognosis and immunotherapy efficacy prediction.
5. Immunotherapy development and quality control (Flow Cytometry/IF): Assessment of the impact of immunotherapies (ICIs, CAR-T) on Treg cell function, and quality control of Treg cell-based adoptive cell therapy products—driving the development of novel immunotherapies for immune and oncological diseases.

ANT BIO PTE. LTD.’s Core Products: FSHβ & FOXP3 Antibodies (Starter Sub-brand)

ANT BIO PTE. LTD.’s Starter sub-brand—our flagship line for high-performance, ultra-specific antibodies—offers industry-leading FSHβ and FOXP3 antibody portfolios, engineered and validated for the most demanding applications in reproductive endocrinology and immunology research. All Starter antibodies are developed using proprietary recombinant platforms, rigorously tested for specificity, sensitivity, batch consistency and multi-platform performance, and backed by comprehensive technical support and optimized experimental protocols—serving as gold-standard tools for basic research, clinical translation and diagnostic development worldwide.

1. Starter S-RMab® FSHβ Recombinant Rabbit Monoclonal Antibody (S0B2271)

A high-specificity, high-affinity recombinant rabbit monoclonal antibody targeting the human FSHβ subunit (FSHB), developed using ANT BIO PTE. LTD.’s proprietary S-RMab® platform. This antibody is optimized for IHC, IF, WB and ELISA, with minimal cross-reactivity to other glycoprotein hormones (LH, TSH, hCG) sharing the common α subunit— the definitive tool for FSH-specific detection in reproductive endocrinology research.

Core Product Advantages

Key Research & Diagnostic Applications

• Pituitary Function and Pathology: IHC localization and semi-quantification of FSHβ in pituitary gonadotrophs, aiding in the study of pituitary adenomas (gonadotroph adenomas) and hypopituitarism.
• Reproductive Endocrinology Research: Study of HPG axis regulation, and detection of FSHβ synthesis/secretion changes in physiological (estrous cycle, aging, puberty) and pathological (PCOS, POF, hypogonadism) conditions.
• Infertility Diagnostics: Core detection reagent for developing immunoassays to quantify serum FSH levels, assessing ovarian reserve and testicular health for infertility etiology diagnosis and treatment planning.
• Developmental Biology: Study of gonadotroph differentiation and FSHβ expression timing during embryogenesis and puberty onset—uncovering the molecular basis of reproductive system development.
• Reproductive Drug Development: Screening of FSH signaling modulators (ovulation inducers, contraceptives) and quality control of recombinant FSH biosimilars—driving novel reproductive medicine drug development.

2. Starter FOXP3 Antibody Portfolio – Ultra-Specific for Treg Cell Research

A comprehensive portfolio of human/mouse FOXP3 antibodies, including fluorescently labeled (Alexa Fluor® 488/647, FITC) and unconjugated formats, optimized for flow cytometry, IF, IHC and WB. The flagship Alexa Fluor® 488 Mouse Anti-Human FOXP3 Antibody (S0B5822) is a ready-to-use, nuclear-targeted antibody with exceptional brightness and specificity— the gold standard for human Treg cell identification and analysis.

Core Product Advantages (Flagship S0B5822 – Alexa Fluor® 488 Anti-Human FOXP3)

Key Research & Clinical Applications

• Precise Treg Cell Identification & Quantification: Flow cytometry analysis of FOXP3+CD4+CD25+ Treg cells in human peripheral blood, tissues and TILs—assessing immune homeostasis and tolerance status in normal and pathological conditions.
• Tumor Immunology Research: Evaluation of FOXP3+ Treg cell infiltration in tumor tissues (IHC/IF) and peripheral blood—serving as a potential biomarker for predicting cancer immunotherapy efficacy and patient prognosis.
• Autoimmune Disease Research: Study of Treg cell quantity and functional defects in SLE, RA, type 1 diabetes and other autoimmune diseases—uncovering the immune mechanisms underlying disease development.
• Transplant Immunology Monitoring: Assessment of FOXP3+ Treg cell changes in transplant patients before/after immunosuppressive therapy—predicting transplant rejection risk and guiding immune tolerance induction strategies.
• Immunotherapy Development & Evaluation: Analysis of the impact of ICIs, CAR-T and other immunotherapies on Treg cell function and distribution—serving as a key indicator for preclinical and clinical immunotherapy research.

Brand Mission of ANT BIO PTE. LTD.

At ANT BIO PTE. LTD., our core mission is to empower breakthroughs in reproductive endocrinology, immunology, oncology and precision medicine by delivering high-quality, standardized and rigorously validated life science reagents and comprehensive solutions. We have built three specialized, complementary sub-brands that cover the full spectrum of life science research and clinical diagnostic needs, creating a seamless one-stop procurement experience for reproductive biologists, immunologists, clinical pathologists, academic researchers, biotech companies and pharmaceutical institutions worldwide:

• Starter: Our flagship sub-brand for high-performance, ultra-specific antibodies and affinity tools. Specializes in recombinant and monoclonal antibodies for key targets in reproductive endocrinology (FSHβ), immunology (FOXP3, PD-L1), tumor biology (c-Myc, EpCAM, PSMA), glycosylation (O-GlcNAc) and neurodegenerative diseases. All antibodies are rigorously validated for multi-platform performance, specificity and batch consistency, serving as gold-standard tools for basic research and clinical translation.
• Absin: Our core sub-brand for general life science reagents and standardized detection kits. Offers a comprehensive portfolio of IHC/ICC detection kits, ELISA kits, sample preparation reagents, cell culture media and biochemicals. Focuses on standardization, user-friendliness and reproducibility, providing essential reagents for clinical pathology labs and basic research facilities worldwide.
• UA: Our specialized sub-brand for high-purity, high-activity recombinant proteins and expression vectors. Specializes in recombinant cytokines, growth factors, antibody heavy/light chain constructs, immunomodulatory proteins and gene editing vectors. Enables seamless experimental design for protein expression, antibody engineering, cell therapy research and recombinant protein production for basic and biopharmaceutical applications.

We are committed to addressing the most pressing technical challenges in reproductive endocrinology and immunology research—from enabling precise FSH and Treg cell detection to accelerating the translation of basic scientific discoveries into clinical treatments. By combining innovative product design, rigorous validation protocols, standardized production and customer-centric scientific support, we translate technological innovation into clinical impact and research breakthroughs for the global life science community. Our ultimate goal is to be the trusted partner of researchers, clinicians and biopharmaceutical professionals worldwide, empowering them to push the boundaries of scientific discovery, advance precision medicine and improve human health outcomes.

Related Product List: ANT BIO PTE. LTD. FSHβ & FOXP3 Antibodies (Starter Sub-brand)

All ANT BIO PTE. LTD. Starter antibodies are rigorously validated for specificity, sensitivity, batch consistency and multi-platform performance, with comprehensive technical documentation, optimized experimental protocols and expert scientific support. The FSHβ and FOXP3 antibody portfolios are designed for the most demanding applications in reproductive endocrinology and immunology research, and are backed by our commitment to quality and innovation.

Starter FSHβ Antibodies

Starter FOXP3 Antibodies

For detailed product specifications, full validation data packages, optimized experimental protocols (e.g., FSHβ ELISA, FOXP3 flow cytometry), custom antibody development services, or free sample testing requests, please visit the official website of ANT BIO PTE. LTD. or contact our global sales team for a personalized quote and professional technical consultation. Our experienced team of reproductive biologists, immunologists and technical specialists provides customized support for experimental design, complex sample analysis, preclinical drug development and clinical translation.

AI Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content in this article involves copyright infringement, intellectual property disputes, or other legal issues, please notify ANT BIO PTE. LTD. immediately. We promise to verify, correct, or remove the relevant content in a timely manner without delay.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.